Eric Venker, President & Immunovant CEO at Roivant Sciences Ltd. (ROIV), sold 234,483 shares at $30.27 ($7.2M) on 2026-05-22, disclosed to the SEC on 2026-05-22.
Seasonal sale ($7.2M) by President & Immunovant CEO — this insider has traded ROIV in May in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $32.41 | 34,483 | $1.1M | 15.6% |
| 2 | $30.27 | 200,000 | $6.1M | 84.4% |
| Total | $30.58 avg | 234,483 | $7.2M | 100% |
| Filing → |
| ROIV | SELL | 2026-09-01 | $7.2M | — | Filing → |
| ROIV | SELL | 2026-07-29 | $7.0M | — | Filing → |
| IMVT | SELL | 2026-07-06 | $119K | — | Filing → |